Tolvaptan and hyponatremia in a patient with cirrhosis [PDF]
Hepatology, 2010 Thomas Boyer
openalex +5 more sources
Tolvaptan, an Oral Vasopressin V2 Receptor Antagonist for Heart Failure? [PDF]
, 2007 Arthur Greenberg
openalex +1 more source
Coadministration of the Vasopressin-2 Receptor Antagonist Tolvaptan and B-Type Natriuretic Peptide Enhances Water and Sodium Excretion without Adversely Affecting Renal or Neurohumoral Function in Experimental Congestive Heart Failure [PDF]
, 2007 Lisa C. Costello‐Boerrigter +3 more
openalex +1 more source
Coadministration of B-type natriuretic peptide and the vasopressin-2 receptor antagonist tolvaptan: a novel physiologic strategy to enhance water and sodium excretion without adversely affecting renal or neurohumoral function in experimental congestive heart failure [PDF]
, 2007 Lisa C. Costello-Boerrigter +3 more
openalex +1 more source
The efficacy and safety of tolvaptan on treating congestive heart failure patients with hyponatremia [PDF]
, 2011 Ling Li, Zhu Wen-ling, Hua Bai
openalex +1 more source
Erratum to: Tolvaptan for Heart Failure Patients with Volume Overload [PDF]
, 2011 Masatsugu Hori
openalex +1 more source
Tolvaptan Improves Left Ventricular Dysfunction after Myocardial Infarction in Rats [PDF]
, 2012 Takanori Yamazaki +10 more
openalex +1 more source
Syndrome of Inappropriate Antidiuretic Hormone Secretion and Ibuprofen, a Rare Association to Be Considered: Role of Tolvaptan [PDF]
, 2013 Nathan Artom +5 more
openalex +1 more source
The vasopressin V2-receptor antagonist, tolvaptan, can not only induce aquaresis but also enhance natriuresis in heart failure patients refractory to loop diuretics [PDF]
, 2013 Yuki Ikeda +9 more
openalex +1 more source
A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan [PDF]
, 2013 Claudia Petereit +4 more
openalex +1 more source